Portugal

Kidney Care Award: bringing value to chronic kidney disease

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 22/10/2026, 11:16:24 UTC.

Briefings

Boehringer Ingelheim launched the Kidney Care Award in 2026 to recognize projects improving outcomes for patients with chronic kidney disease. The initiative aims to support innovative initiatives that enhance patient care and quality of life. No specific projects were named, and the award criteria remain undefined in the provided text.

Key points

• The Kidney Care Award was launched in 2026 by Boehringer Ingelheim to recognize projects with potential to improve the response to chronic kidney disease.
• The award is open for submission, but specific criteria and named recipients are not provided in the source evidence.

Context

This initiative represents a recent effort by a major pharmaceutical company to support research and development in the field of chronic kidney disease management.

Limitations

The evidence is limited to the announcement of the award launch in 2026. Specific criteria, named projects, and the exact number of recipients are not available in the source text.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 22/10/2026, 11:48:20 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeianmbokgb2lxxissob7ydsh5zdutkzfhrg3b2rkbwahjukzl73omi